- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07224828
The Efficacy of a Battery Toothbrush in the Reduction of Established Plaque and Gingivitis
Clinical Investigation to Assess the Efficacy of a Battery Toothbrush in the Reduction of Established Plaque and Gingivitis: a 12-week Clinical Study.
A clinical research study design to compare the effectiveness of a battery toothbrush and dentifrice in reducing gingivitis and dental plaque in adults.
Study Overview
Status
Conditions
Detailed Description
This is a Phase III, randomized, single-center, parallel group, triple blind, clinical research study design to compare the effectiveness of a battery toothbrush and dentifrice in reducing gingivitis and dental plaque in adults. This study will have 3 arms to determine the efficacy of a battery toothbrush vs a positive control regimen and a negative control regimen to reduce plaque and gingivitis.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
San Juan, Puerto Rico, 00927
- Dental Research Associates, Inc.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male and Female, age 18-70, inclusive.
- Availability for the 12-week duration of the clinical research study.
- Good general health at the discretion of the dental examiner or study investigators.
- Minimum of 20 permanent natural teeth (excluding third molars).
- Initial gingivitis index of at least 1.0 as determined by the use of the Loe and Silness Gingival Index.
- Initial mean plaque index of at least 0.6 as determined by Rustogi Modification of the Navy plaque index.
- Signed Informed Consent Form
Exclusion Criteria:
- Presence of orthodontic appliances.
- Presence of partial removable dentures.
- Oral pathology, chronic disease or tumor(s) of the soft or hard tissues of the oral cavity.
- Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone).
- Five or more carious lesions requiring immediate restorative treatment.
- Use of anticonvulsants, sedatives, tranquilizers, anti-inflammatory or daily analgesics within one month prior to the start of the study or scheduled to start such intake during the course of the study.
- Use of antibiotics any time during the one-month period prior to entry into the study.
- Ongoing use of medications known to affect gingival tissues (i.e. calcium channel blockers, phenytoin, cyclosporine) and/or on any prescription medicines that might interfere with the study outcome.
- Participation in any other clinical study.
- Self-reported pregnancy and/or breastfeeding.
- Dental prophylaxis within the past three weeks prior to baseline examinations.
- Current allergies and/or history of allergic reactions to oral care products, personal care consumer products, or any of their ingredients.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Test 1
instructed to brush their teeth for two (2) minutes twice a day (morning and evening) with the toothpaste and toothbrush provided. |
0.454 Stannous Fluoride toothpaste with battery toothbrush |
|
Active Comparator: Test 2
instructed to brush their teeth for two (2) minutes twice a day (morning and evening) with the toothpaste and toothbrush provided. |
regular fluoride toothpaste with battery toothbrush |
|
Active Comparator: Test 3
instructed to brush their teeth for two (2) minutes twice a day (morning and evening) with the toothpaste and toothbrush provided. |
regular fluoride toothpaste with manual toothbrush |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Löe and Silness Gingival Index
Time Frame: baseline,6 week, 12 week
|
score from 0 to 3 will be assigned by the examining dentist to all scorable surfaces of the maxillary and mandibular teeth using a dental light and dental mirror. A whole mouth mean score for each subject will be determined by adding the values given by the examining dentist to each scorable surface and dividing that number by the total number of surfaces scored. |
baseline,6 week, 12 week
|
|
Rustogi Mod. Navy Plaque Index
Time Frame: baseline, 6 week, 12 week
|
An expanded form of the Rustogi Modified Navy Plaque Index, used to measure plaque on different surfaces of teeth. Plaque disclosing solution used |
baseline, 6 week, 12 week
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Augusto R. Elias-Boneta, DMD.MSD, Dental Research Associates
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CRO-2025-4-PG-BTB-PR-DR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.